期刊文献+

他莫昔芬通过容积激活性氯电流抑制肝癌细胞增殖

Effects of Tamoxifen on proliferation and volume-activated chloride current in human hepatocellular carcinoma cells
暂未订购
导出
摘要 目的:探讨他莫昔芬(TAM)对人肝癌SMMC7721细胞增殖的影响以及与容积激活性氯电流的关系。方法:MTT法检测TAM对细胞增殖的作用;流式细胞术检测TAM对细胞周期的影响;全细胞膜片钳技术观察TAM对容积激活性氯电流的抑制作用。结果:TAM能浓度依赖性地抑制SMMC7721细胞的增殖和低渗激活的容积激活性氯电流,两者呈正向直线相关;TAM也阻滞细胞周期于G0/G1期。结论:TAM通过调节容积激活性氯通道的开放抑制SMMC7721细胞的增殖,容积激活性氯通道可能是TAM抗肿瘤特别是雌激素受体阴性肿瘤的靶点。 Objective: To investigate the role of the volume-activated chloride current (Icl,vol)on inhibition effects of tamoxifen on the proliferation in human hepatocellular carcinoma cells SMMC 7721. Methods: MTT assay was used to determine the inhibition of TAM on cell proliferation. The whole cell patch clamp technique was used to observe the effects of tamoxifen on Icl,vol. Results: Tamoxifen inhibited the cell proliferation, Icl,vol in a concentration-dependent manner and arrested cell cycle on G0/G1 phase. Analysis of the relationships between the current and cell proliferation showed that the current was positively correlated with cell proliferation. Condusion: These data indicate that tamoxifen may inhibit cell proliferation by modulating Icl,vol. The Icl,vol may be an extra-estrogen receptor site of action for tamoxifen and may account, in part, for its anti-growth effects on estrogen receptor-negative cancers.
出处 《中国医药导报》 CAS 2009年第19期39-41,共3页 China Medical Herald
基金 国家自然科学基金(30800435) 广东省医学科研基金(B2008086)
关键词 肝癌 他莫昔芬 细胞增殖 氯通道 Hepatocellular carcinoma Tamoxifen Cell proliferation Chloride channels
  • 相关文献

参考文献4

二级参考文献30

  • 1林天歆,褚忠华,黄健,许可慰,李泗耀,黄海,尹心宝,江春.雌激素受体α上调前列腺癌细胞株LNCaP中L-Plastin启动子转录活性研究[J].中华实验外科杂志,2005,22(11):1364-1366. 被引量:4
  • 2Kaiser U, Hofmann J, Schilli M, et al. Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer[J]. Int J Cancer,1996, 67: 357-364.
  • 3Ho GH, Ji CY, Phang BH, et al. Tamoxifen alters levels of serum insulin-like growth factors and binding proteins in postmenopausal breast cancer patients: a prospective paired cohort study[J]. Ann Surg Oncol, 1998, 5: 361-367.
  • 4England GM, Jordan VC. Pure antiestrogens as a new therapy for breast cancer[J]. Oncol Res, 1997, 9: 397-402.
  • 5Luo S, Martel C, Sourla A, et al. Comparative effects of 28-day treatment with the new antiestrogen EM-800 and tamoxifen on estrogen-sensitive parameters in intact mice[J]. Int J Cancer, 1997, 73: 381-391.
  • 6Lonning PE. Aromatase inhibitors and their future role in post-menopausal women with early breast cancer[J]. Br J Cancer, 1998, 78: 12-15.
  • 7Blamey RW. The role of selective non-steroidal aromatase inhibitors in future treatment strategies[J]. Oncology, 1997, 54: 27-31.
  • 8Harkonen PL, Makela SI. Role of estrogens in development of prostate cancer. J Steroid Bioehem Mol Biol, 2004,92 : 297-305.
  • 9Xiong Y, Hannon G, Zhang H, et al. P21 is a universal inhibitor of cyclin kinases. Nature, 1993,366 : 701-704.
  • 10Klan Tee M, Rogatsky l,Tzagarakis-Foster C, et al. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors α and β. Mol Biol Cell, 2004,15 : 1262-1272.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部